Cerebral Amyloid Angiopathy-How to Translate Updated Diagnostic Criteria for This Multifaceted Disorder to Clinical Practice?

Geert Jan Biessels; Ana Sofia Costa

doi:10.1001/jamaneurol.2022.5060

Cerebral Amyloid Angiopathy-How to Translate Updated Diagnostic Criteria for This Multifaceted Disorder to Clinical Practice?

JAMA Neurol. 2023 Mar 1;80(3):225-226. doi: 10.1001/jamaneurol.2022.5060.

Authors

Geert Jan Biessels¹, Ana Sofia Costa^{2

3}

Affiliations

¹ Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
² Department of Neurology, University Hospital RWTH Aachen, Aachen, Germany.
³ JARA Institute Molecular Neuroscience and Neuroimaging (INM-11), Research Center Juelich and RWTH Aachen, Aachen, Germany.

PMID: 36689205
DOI: 10.1001/jamaneurol.2022.5060

No abstract available

Plain language summary

This Viewpoint discusses recent efforts to update diagnostic criteria for cerebral amyloid angiopathy as well as questions and challenges in counseling patients about prognosis and deciding on optimal treatment.

MeSH terms

Cerebral Amyloid Angiopathy* / diagnosis
Cerebral Amyloid Angiopathy* / diagnostic imaging
Cerebral Hemorrhage
Humans
Magnetic Resonance Imaging